Free shipping on all orders over $ 500

AZD6765

Cat. No. M1897

All AbMole products are for research use only, cannot be used for human consumption.

AZD6765 Structure
Size Price Availability
10mg USD 180 Out of stock
50mg USD 480 Out of stock
200mg USD 900 Out of stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

AZD6765, a low-trapping NMDA channel blocker in development for major depression, is predicted to have an improved tolerability profile compared to ketamine. Preclinically, NMDA channel blockers increase gamma-band EEG - a potential therapeutic biomarker of cortical disinhibition. Significant increases in gamma-band EEG were observed at 1 hour for AZD6765 and ketamine, and baseline-corrected gamma-band EEG following AZD6765 150 mg was statistically indistinguishable from that observed following ketamine. AZD6765 demonstrated NMDA channel blockade and an improved tolerability profile compared to ketamine. AZD6765 demonstrated NMDA channel blockade and an improved tolerability profile compared to ketamine.

Chemical Information
Molecular Weight 198.26
Formula C13H14N2
CAS Number 153322-05-5
Form Liquid
Solubility (25°C) DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Ioline D Henter, et al. Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status

[2] Vivian B Neis, et al. The involvement of PI3K/Akt/mTOR/GSK3β signaling pathways in the antidepressant-like effect of AZD6765

[3] Samuel T Wilkinson, et al. A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate/GABA neurotransmitter systems

[4] Ioline D Henter, et al. Glutamatergic Modulators in Depression

[5] Lorenz Deutschenbaur, et al. Role of calcium, glutamate and NMDA in major depression and therapeutic application

Related GluR Products
LY404039

LY404039 is a potent, selective and orally active agonist of recombinant human mGlu2, mGlu3 receptors with Ki of 149 nM, 92 nM respectively.

Felbamate

Felbamate(Felbatol) is an anticonvulsant compound used in epilepsy research.

CTEP

CTEP (RO4956371) is a novel, long-acting, orally bioavailable allosteric antagonist of mGlu5 receptor with IC50 of 2.2 nM, shows >1000-fold selectivity over other mGlu receptors.

VU 0361737

VU 0361737 is a selective positive allosteric modulator (PAM) for mGlu4 receptor with EC50 of 240 nM and 110 nM at human and rat receptors, respectively.

Ampalex

Ampalex is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator which can be used for the research of Alzheimer's disease, schizophrenia and mild cognitive impairment (MCI).

  Catalog
Abmole Inhibitor Catalog




Keywords: AZD6765 supplier, GluR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.